Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Xanthohumol improves cognition in farnesoid X receptor-deficient mice on a high-fat diet

Detalhes bibliográficos
Main Authors:	Payel Kundu, Ines L. Paraiso, Jaewoo Choi, Cristobal L. Miranda, Chrissa Kioussi, Claudia S. Maier, Gerd Bobe, Jan F. Stevens, Jacob Raber
Formato:	Artigo
Idioma:	English
Publicado em:	The Company of Biologists 2022-11-01
Colecção:	Disease Models & Mechanisms
Assuntos:	western diet hippocampus water maze ceramides diacylglycerols farnesoid x receptor
Acesso em linha:	http://dmm.biologists.org/content/15/11/dmm049820

Registos relacionados

Theabrownin alleviates nonalcoholic fatty liver disease by inhibiting the intestinal farnesoid X receptor–ceramide axis
Por: Jieyi Wang, et al.
Publicado em: (2024-07-01)

ApoE isoform-dependent effects of xanthohumol on high fat diet-induced cognitive impairments and hippocampal metabolic pathways
Por: Payel Kundu, et al.
Publicado em: (2022-10-01)

Changes in Plasma Bioactive Lipids and Inflammatory Markers during a Half-Marathon in Trained Athletes
Por: Melania Gaggini, et al.
Publicado em: (2021-05-01)

A high‐fat diet supplemented with medium‐chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice
Por: Stephanie Mourad, et al.
Publicado em: (2024-03-01)

Human Brain Lipidomics: Investigation of Formalin Fixed Brains
Por: Aaron W. Beger, et al.
Publicado em: (2022-06-01)

Effects of Fish Oil and Grape Seed Extract Combination on Hepatic Endogenous Antioxidants and Bioactive Lipids in Diet-Induced Early Stages of Insulin Resistance in Rats
Por: Núria Taltavull, et al.
Publicado em: (2020-06-01)

Two Different Phospholipases C, Isc1 and Pgc1, Cooperate To Regulate Mitochondrial Function
Por: Maria Balazova, et al.
Publicado em: (2022-12-01)

Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane
Por: Gergana Deevska, et al.
Publicado em: (2021-05-01)

Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
Por: Hongshan Li, et al.
Publicado em: (2022-08-01)

Stimulation of the farnesoid X receptor promotes M2 macrophage polarization
Por: Thiranut Jaroonwitchawan, et al.
Publicado em: (2023-01-01)

Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota
Por: Annika Wahlström, et al.
Publicado em: (2017-02-01)

Farnesoid X Receptor, Bile Acid Metabolism, and Gut Microbiota
Por: Hideki Mori, et al.
Publicado em: (2022-07-01)

Effect of a Farnesoid X-receptor Agonist on Postprandial Lipemia in Rats Fed a Supraphysiological Fat Dozes
Por: Yu. N. Alekhin, et al.
Publicado em: (2023-05-01)

Imaging the early stages of phospholipase C/sphingomyelinase activity on vesicles containing coexisting ordered-disordered and gel-fluid domains[S]
Por: Maitane Ibarguren, et al.
Publicado em: (2011-04-01)

Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes
Por: Apollinariya V. Bogolyubova, et al.
Publicado em: (2017-12-01)

Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
Por: Jianglian She, et al.
Publicado em: (2022-01-01)

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis
Por: Joana Torres, et al.
Publicado em: (2017-10-01)

Role of farnesoid X receptor and bile acids in alcoholic liver disease
Por: Sharon Manley, et al.
Publicado em: (2015-03-01)

Experimental Activation of Endocannabinoid System Reveals Antilipotoxic Effects on Cardiac Myocytes
Por: Ewa Harasim-Symbor, et al.
Publicado em: (2020-04-01)

Phospholipases and Membrane Curvature: What Is Happening at the Surface?
Por: María Laura Fanani, et al.
Publicado em: (2023-02-01)

Punicalagin alleviates hypercholesterolemia in mice through modulating farnesoid X receptor signaling and modulating gut microbiota
Por: Huanhuan Liu, et al.
Publicado em: (2025-01-01)

A combined nanotherapeutic approach targeting farnesoid X receptor, ferroptosis, and fibrosis for nonalcoholic steatohepatitis treatment
Por: Jiangtao Fu, et al.
Publicado em: (2024-05-01)

Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway
Por: Yang Fan, et al.
Publicado em: (2023-11-01)

PRIMIS: design of a pivotal, randomized, phase 3 study evaluating the safety and efficacy of the nonsteroidal farnesoid X receptor agonist cilofexor in noncirrhotic patients with primary sclerosing cholangitis
Por: Michael Trauner, et al.
Publicado em: (2023-03-01)

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity
Por: Vahid Jamshidi, et al.
Publicado em: (2021-11-01)

Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension
Por: John D. Imig
Publicado em: (2023-06-01)

Bile Acids Elevated in Chronic Periaortitis Could Activate Farnesoid-X-Receptor to Suppress IL-6 Production by Macrophages
Por: Shan Cao, et al.
Publicado em: (2021-04-01)

Loss of Farnesoid X receptor (FXR) accelerates dysregulated glucose and renal injury in db/db mice
Por: Yuxiang Qiu, et al.
Publicado em: (2023-09-01)

Proteomics and lipidomic analysis reveal dysregulated pathways associated with loss of sacsin
Por: Daniele Galatolo, et al.
Publicado em: (2024-06-01)

Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA
Por: Longying Jiang, et al.
Publicado em: (2023-01-01)

Alpha-linolenic acid inhibits hepatocellular carcinoma cell growth through Farnesoid X receptor/β-catenin signaling pathway
Por: Shu Feng, et al.
Publicado em: (2022-08-01)

Upregulation of microRNA-23b-3p induced by farnesoid X receptor regulates the proliferation and apoptosis of osteosarcoma cells
Por: Bin Wu, et al.
Publicado em: (2019-11-01)

Farnesoid X receptor regulates forkhead Box O3a activation in ethanol-induced autophagy and hepatotoxicity
Por: Sharon Manley, et al.
Publicado em: (2014-01-01)

Role of farnesoid X receptor in establishment of ontogeny of phase-I drug metabolizing enzyme genes in mouse liver
Por: Lai Peng, et al.
Publicado em: (2016-09-01)

Computational study of novel natural agonists targeting farnesoid X receptor
Por: Xindan Hu, et al.
Publicado em: (2024-07-01)

Arbutin Alleviates the Liver Injury of α-Naphthylisothiocyanate-induced Cholestasis Through Farnesoid X Receptor Activation
Por: Peijie Wu, et al.
Publicado em: (2021-12-01)

Mangrove Tirucallane- and Apotirucallane-Type Triterpenoids: Structure Diversity of the C-17 Side-Chain and Natural Agonists of Human Farnesoid/Pregnane–X–Receptor
Por: Zhong-Ping Jiang, et al.
Publicado em: (2018-12-01)

The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity
Por: Kemp M. Anderson, et al.
Publicado em: (2021-11-01)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
Por: Berggren-Söderlund Maria, et al.
Publicado em: (2011-11-01)

Farnesoid-X receptor as a therapeutic target for inflammatory bowel disease and colorectal cancer
Por: Mengjiao Zhou, et al.
Publicado em: (2022-10-01)